Breaking News Instant updates and real-time market news.

AKAO

Achaogen

$7.00

0.13 (1.89%)

07:27
08/07/18
08/07
07:27
08/07/18
07:27

Achaogen downgraded to Hold from Buy at Needham

  • 14

    Aug

  • 30

    Aug

  • 31

    Aug

AKAO Achaogen
$7.00

0.13 (1.89%)

05/07/18
GUGG
05/07/18
DOWNGRADE
GUGG
Neutral
Achaogen downgraded to Neutral from Buy at Guggenheim
06/27/18
HCWC
06/27/18
NO CHANGE
Target $19
HCWC
Buy
Achaogen selloff following FDA approval excessive, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce attributes the pullback in Achaogen shares after the company announced yesterday the FDA approval of Zemdri for cUTI to disappointment that the FDA did not also approve plazomicin for CRE infections via a bloodstream infections indication. However, while he believes a BSI indication would have been helpful, he thinks it is "by no means necessary" to successfully market Zemdri for CRE and he calls yesterday's selloff "excessive." Arce affirms a Buy rating on Achaogen shares with a $19 price target.
07/13/18
WBLR
07/13/18
NO CHANGE
WBLR
Outperform
Achaogen 30% pullback since last month overdone, says William Blair
After attending the company's investor event, William Blair analyst Y. Katherine Xu says shares of Achaogen at current levels offer an attractive entry opportunity. While most of the Street has modeled the use of Zemdri in carbapenem-resistant enterobacteriaceae, extended-spectrum beta-lactamases-producing bacteria is also a major target and represents a much larger population, Xu tells investors in a research note. Further, she believes physicians are and will be comfortable to use Zemdri off-label in blood stream infections and pneumonia. The analyst views the 30% pullback in Achaogen shares since the complicated urinary tract infections approval last month as overdone and thinks her $23 fair value estimate could prove conservative. Xu keeps an Outperform rating on Achaogen.
08/03/18
08/03/18
NO CHANGE

Achaogen's Zemdri granted NTAP status by the CMS
Achaogen announced that the Centers for Medicare & Medicaid Services - CMS - has granted a new technology add-on payment, or NTAP, for Zemdri when administered in the hospital inpatient setting. The NTAP program will provide hospitals with a payment, in addition to the standard-of-care Diagnostic Related Group reimbursement, of up to 50% of the cost of Zemdr ifor a period of two to three years, effective in the 2019 fiscal year starting on October 1, 2018. CMS has assigned a maximum payment of $2,722.50 for a patient treated with ZEMDRI.

TODAY'S FREE FLY STORIES

VOYA

Voya Financial

$46.21

1.625 (3.64%)

13:11
11/13/18
11/13
13:11
11/13/18
13:11
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya sees dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VOYA

Voya Financial

$46.38

1.795 (4.03%)

13:10
11/13/18
11/13
13:10
11/13/18
13:10
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial targets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VOYA

Voya Financial

$46.38

1.795 (4.03%)

13:10
11/13/18
11/13
13:10
11/13/18
13:10
Earnings
Breaking Earnings news story on Voya Financial »

Voya Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

13:08
11/13/18
11/13
13:08
11/13/18
13:08
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

CVE

Cenovus Energy

$8.51

-0.185 (-2.13%)

13:05
11/13/18
11/13
13:05
11/13/18
13:05
Options
Cenovus Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$9.39

0.06 (0.64%)

12:58
11/13/18
11/13
12:58
11/13/18
12:58
Hot Stocks
Infosys to open technology and innovation hub in Texas, hire 500 workers by 2020 »

Infosys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

SNE

Sony

$51.64

0.09 (0.17%)

, MSFT

Microsoft

$107.45

0.56 (0.52%)

12:56
11/13/18
11/13
12:56
11/13/18
12:56
OnTheFly
Game On: Take-Two says 'Red Dead 2' has outsold first 'RDR' in just eight days »

Welcome to "Game On," The…

SNE

Sony

$51.64

0.09 (0.17%)

MSFT

Microsoft

$107.45

0.56 (0.52%)

T

AT&T

$30.63

-0.17 (-0.55%)

NTDOY

Nintendo

$0.00

(0.00%)

ATVI

Activision Blizzard

$52.93

-0.97 (-1.80%)

TTWO

Take-Two

$108.52

-0.51 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

VOYA

Voya Financial

$46.38

1.795 (4.03%)

12:55
11/13/18
11/13
12:55
11/13/18
12:55
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

M

Macy's

$36.27

-0.77 (-2.08%)

, APRN

Blue Apron

$1.17

-0.08 (-6.40%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$36.27

-0.77 (-2.08%)

APRN

Blue Apron

$1.17

-0.08 (-6.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

WIX

Wix.com

$91.01

2.54 (2.87%)

, REZI

Resideo

$21.90

0.56 (2.62%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Earnings
Notable companies reporting after market close »

Notable companies…

WIX

Wix.com

$91.01

2.54 (2.87%)

REZI

Resideo

$21.90

0.56 (2.62%)

SWCH

Switch

$9.16

-0.18 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

SIRI

Sirius XM

$6.26

0.15 (2.46%)

12:47
11/13/18
11/13
12:47
11/13/18
12:47
Conference/Events
Sirius XM management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

OESX

Orion Energy

$0.80

-0.0501 (-5.89%)

12:44
11/13/18
11/13
12:44
11/13/18
12:44
Recommendations
Orion Energy analyst commentary  »

Orion Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.05

0.14 (0.21%)

12:41
11/13/18
11/13
12:41
11/13/18
12:41
Periodicals
Starbucks lays off 5%, or 350, corporate employees, Seattle Times reports »

As part of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$46.01

1.29 (2.88%)

12:40
11/13/18
11/13
12:40
11/13/18
12:40
Options
8.2K Metlife Jan 47.5 - 50 call spreads bought for 82c »

8.2K Metlife Jan 47.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CKPT

Checkpoint Therapeutics

$2.37

0.19 (8.72%)

12:38
11/13/18
11/13
12:38
11/13/18
12:38
Hot Stocks
Checkpoint Therapeutics director Lindsay Rosenwald buys 100K shares of stock »

Checkpoint Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEAR

Turtle Beach

$15.81

0.56 (3.67%)

12:35
11/13/18
11/13
12:35
11/13/18
12:35
Options
Turtle Beach put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KORS

Michael Kors

$49.26

1.51 (3.16%)

12:34
11/13/18
11/13
12:34
11/13/18
12:34
Hot Stocks
Michael Kors CEO sees double digit revenue growth in 2020 »

Michael Kors Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.02

0.11 (0.16%)

12:32
11/13/18
11/13
12:32
11/13/18
12:32
Periodicals
Starbucks to lay off 5% of corporate workforce, Dow Jones says »

The layoffs, which total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VOYA

Voya Financial

$46.22

1.635 (3.67%)

12:29
11/13/18
11/13
12:29
11/13/18
12:29
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NIO

NIO Inc.

$6.77

0.12 (1.80%)

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Conference/Events
William Blair specialty finance analyst holds a group luncheon »

Specialty Finance Analyst…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

, VMW

VMware

$151.32

3.16 (2.13%)

12:24
11/13/18
11/13
12:24
11/13/18
12:24
Periodicals
Dell considering raising bid for DVMT tracking stock, Reuters says »

Dell Technologies (DVMT)…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

VMW

VMware

$151.32

3.16 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

AKRX

Akorn

$6.74

0.02 (0.30%)

, TEVA

Teva

$23.78

0.09 (0.38%)

12:18
11/13/18
11/13
12:18
11/13/18
12:18
Periodicals
Court rules Allergan's patents on Restasis are invalid, Bloomberg reports »

The U.S. Court of Appeals…

AKRX

Akorn

$6.74

0.02 (0.30%)

TEVA

Teva

$23.78

0.09 (0.38%)

AGN

Allergan

$163.97

0.15 (0.09%)

MYL

Mylan

$36.19

0.25 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/13/18
11/13
12:17
11/13/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

, SPX

S&P 500

$0.00

(0.00%)

12:16
11/13/18
11/13
12:16
11/13/18
12:16
Periodicals
John Kelly may soon depart Trump administration, NBC News reports »

Chief of Staff John Kelly…

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.